
All Presentations are in PDF format
William Barlow, PhD
BCSC Risk Model
Joan Bottorff, Ph.D, RN, FCAHS
Reporting Risk to Women: Reponses to Mammographic Density
R. James Brenner, MD, JD, FACR, FCLM
Breast Density and Risk Assessment: The Mammographer’s Perspective
Celia Byrne, PhD
Hormonal Determinants of Breast Density
Elizabeth Claus, MD, PhD
Risk Models for Hereditary Breast Cancer
Carolyn Crandall, MD
Increases in Serum Estrone Sulfate Level are Associated with Increased Mammographic Density During Menopausal Hormone Therapy
Jane Ding, PhD
Qualitative Assessment of Mammographic Density
Mitch Gail, MD, PhD
A Model for Absolute Invasive Breast Cancer Risk that Includes Mammographic Density
Sue Hankinson, MPH, ScD
Sex hormones and risk: Include them in models?
Ralph Highnam, PhD
Standard Mammogram Form
John Shepherd, PhD
Automated Volumetric Density
Rulla M. Tamimi, ScD
Mammographic Density and Receptor Status of Subsequent Breast Tumors
Jeff Tice, MD
The Breast Density Model A simpler BCSC model
Thea Tlsty, PhD
Biological Basis of Breast Density and Cancer Risk
Celine Vachon, PhD
Genetic Influences on Mammographic Density
Martijn Verheus, MSc
No Relationship between Circulating Levels of Sex Steroids and Breast Density; the Prospect-EPIC cohort
Martin Yaffe, Ph.D.
Improving the Accuracy in Measurement of Breast Density
and email addresses
The next Workshops on Breast Densitometry and Mammography-based Assessment of Breast Cancer Risk will be in the Spring of 2008
Sponsored by the
Da Costa International Funds for Breast
Cancer Prevention
Contributions by,
Eli Lilly and Company
Hologic/R2 Technology
Synarc

